Regulatory Effects of Nutritional and Metabolic Disorders on Vascular Calcification in Chronic Kidney Disease: a Narrative Review

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2023 Nov 16

PMID 37970595

Authors

Yuqin Xiong

Yang Yu

Baihai Su

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Vascular calcification (VC) is common in chronic kidney disease (CKD) patients and is associated with poor cardiovascular outcomes. This study aims to review nutritive pro-calcifying factors of CKD.

Methods: Electronic databases (PubMed, Embase, and the Cochrane Central Register of Controlled Trials) were searched from 2001 as at July 26, 2022, to select and summarize the basic and clinical studies reporting the effects of malnutrition or metabolic disorders on VC in CKD and the evolving treatments for these nutrient metabolic disorders.

Key Content And Findings: Hyperphosphatemia, calcium load, hypomagnesemia, iron deficiency, lipoprotein(a) abnormalities, protein malnutrition, and vitamin K deficiency secondary to CKD were closely associated with the occurrence and development of VC. Elevated phosphate and calcium levels were essential contributors to VC, yet current phosphate binders with good phosphate-lowering effects had not been shown to delay VC progression in CKD, and it remained challenging on how to identify and prevent calcium overload. Magnesium supplementation was the most promising treatment for mitigating VC, as supported by and studies and clinical trials. Correction of iron and vitamin K deficiency might contribute to VC attenuation, yet there was a lack of clinical evidence on CKD patients.

Conclusions: This review highlighted the effects of nutrient metabolism disorders on CKD-VC, and additional studies are needed to further address optimal nutrition strategies for mitigating VC in CKD.

Citing Articles

The Physiological Functions and Therapeutic Potential of Hypoxia-Inducible Factor-1α in Vascular Calcification.

Zhang Z, Wang D, Xu R, Li X, Wang Z, Zhang Y Biomolecules. 2025; 14(12.

PMID: 39766299 PMC: 11674127. DOI: 10.3390/biom14121592.

Association of intradialysis blood sodium level, blood pressure variability, and hydration status with hemodialysis-related headache: a prospective cohort study.

Xiong Y, You N, Liao R, Wu L, Liu Y, Ling Z J Headache Pain. 2023; 24(1):166.

PMID: 38082228 PMC: 10712180. DOI: 10.1186/s10194-023-01701-2.

References

Guerin A, London G, Marchais S, Metivier F . Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15(7):1014-21. DOI: 10.1093/ndt/15.7.1014. View

Westenfeld R, Krueger T, Schlieper G, Cranenburg E, Magdeleyns E, Heidenreich S . Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2011; 59(2):186-95. DOI: 10.1053/j.ajkd.2011.10.041. View

Andrews J, Psaltis P, Bayturan O, Shao M, Stegman B, Elshazly M . Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound. JACC Cardiovasc Imaging. 2017; 11(9):1315-1323. DOI: 10.1016/j.jcmg.2017.04.010. View

Ketteler M, Sprague S, Covic A, Rastogi A, Spinowitz B, Rakov V . Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrol Dial Transplant. 2018; 34(7):1163-1170. PMC: 6603395. DOI: 10.1093/ndt/gfy127. View

Ter Braake A, Smit A, Bos C, van Herwaarden A, Alkema W, van Essen H . Magnesium prevents vascular calcification in Klotho deficiency. Kidney Int. 2019; 97(3):487-501. DOI: 10.1016/j.kint.2019.09.034. View

Ciceri P, Falleni M, Tosi D, Martinelli C, Cannizzo S, Marchetti G . Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis. Int J Mol Sci. 2019; 20(23). PMC: 6928632. DOI: 10.3390/ijms20235925. View

Ruospo M, Palmer S, Natale P, Craig J, Vecchio M, Elder G . Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database Syst Rev. 2018; 8:CD006023. PMC: 6513594. DOI: 10.1002/14651858.CD006023.pub3. View

Cunningham J, Rodriguez M, Messa P . Magnesium in chronic kidney disease Stages 3 and 4 and in dialysis patients. Clin Kidney J. 2015; 5(Suppl 1):i39-i51. PMC: 4455820. DOI: 10.1093/ndtplus/sfr166. View

Yamada S, Tokumoto M, Tsuruya K, Tatsumoto N, Noguchi H, Kitazono T . Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. Am J Physiol Renal Physiol. 2015; 309(8):F744-54. DOI: 10.1152/ajprenal.00017.2015. View

10.

Bressendorff I, Hansen D, Pasch A, Holt S, Schou M, Brandi L . The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial. Nephrol Dial Transplant. 2019; 36(4):713-721. DOI: 10.1093/ndt/gfz234. View

11.

Ter Braake A, Vervloet M, de Baaij J, Hoenderop J . Magnesium to prevent kidney disease-associated vascular calcification: crystal clear?. Nephrol Dial Transplant. 2020; 37(3):421-429. PMC: 8875474. DOI: 10.1093/ndt/gfaa222. View

12.

Zheng K, Tsimikas S, Pawade T, Kroon J, Jenkins W, Doris M . Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis. J Am Coll Cardiol. 2019; 73(17):2150-2162. PMC: 6494952. DOI: 10.1016/j.jacc.2019.01.070. View

13.

Witham M, Lees J, White M, Band M, Bell S, Chantler D . Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial. J Am Soc Nephrol. 2020; 31(10):2434-2445. PMC: 7609010. DOI: 10.1681/ASN.2020020225. View

14.

Leenders N, Bos C, Hoekstra T, Schurgers L, Vervloet M, Hoenderop J . Dietary magnesium supplementation inhibits abdominal vascular calcification in an experimental animal model of chronic kidney disease. Nephrol Dial Transplant. 2022; 37(6):1049-1058. PMC: 9130027. DOI: 10.1093/ndt/gfac026. View

15.

Garcia-Torres R, Young L, Murray D, Kheda M, Nahman Jr N . Dietary Protein Source and Phosphate Levels in Patients on Hemodialysis. J Ren Nutr. 2020; 30(5):423-429. DOI: 10.1053/j.jrn.2019.11.006. View

16.

Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S . A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD. J Am Soc Nephrol. 2019; 30(6):1073-1085. PMC: 6551769. DOI: 10.1681/ASN.2018111150. View

17.

Masumoto A, Sonou T, Ohya M, Yashiro M, Nakashima Y, Okuda K . Calcium Overload Accelerates Phosphate-Induced Vascular Calcification Via Pit-1, but not the Calcium-Sensing Receptor. J Atheroscler Thromb. 2016; 24(7):716-724. PMC: 5517545. DOI: 10.5551/jat.36574. View

18.

Rogers M, Atkins S, Zheng K, Singh S, Chelvanambi S, Pham T . Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis. Front Cardiovasc Med. 2022; 9:778919. PMC: 8831739. DOI: 10.3389/fcvm.2022.778919. View

19.

Carrero J, Thomas F, Nagy K, Arogundade F, Avesani C, Chan M . Global Prevalence of Protein-Energy Wasting in Kidney Disease: A Meta-analysis of Contemporary Observational Studies From the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018; 28(6):380-392. DOI: 10.1053/j.jrn.2018.08.006. View

20.

Toth P, Dwyer J, Cannon C, Colhoun H, Rader D, Upadhyay A . Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease. Kidney Int. 2018; 93(6):1397-1408. DOI: 10.1016/j.kint.2017.12.011. View